|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 |
| (11) | Number of the document | 1631308 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04754133.9 |
| Date of filing the European patent application | 2004-05-28 | |
| (97) | Date of publication of the European application | 2006-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2013-07-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/017456 |
| Date | 2004-05-28 |
| (87) | Number | WO 2005/000222 |
| Date | 2005-01-06 |
| (30) | Number | Date | Country code |
| 474233 P | 2003-05-30 | US |
| (72) |
ONG, John, T., H., US
STETSKO, Gregg, US
JENNINGS, Robert, US
|
| (73) |
Amylin Pharmaceuticals, LLC,
9360 Towne Centre Drive, San Diego, CA 92121,
US
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE, US |
| (54) | NOVEL METHODS AND COMPOSITIONS FOR ENHANCED TRANSMUCOSAL DELIVERY OF PEPTIDES AND PROTEINS |
| NOVEL METHODS AND COMPOSITIONS FOR ENHANCED TRANSMUCOSAL DELIVERY OF PEPTIDES AND PROTEINS |